April 16, 2021

April 16^th, 2021

Meeting Minutes: QI Collaborative Clinical Leadership Meeting

Key points:

• Collaborative growth: we now have 34 clinics participating!
  • 24 pediatric sites, 10 adult sites
  • Welcome to UCSF Health adult and pediatric clinics!
• Adult Measures
  • Phase 1 goals
  • Phase 2 goals
    • Common definition for DKA events and admissions
      • Does not strictly include hospital admissions and can include patient reported admissions. Please see DKA definitions, below[1].
    • Phase 3 goals: decisions for these measures will be made during a working group in the future. Adult PIs, you will be invited to participate in this process.
  • Pediatric Measures
    • Phase 1 goals
    • Phase 2 goals
    • Phase 3 goals
      • Switch language from “loss to follow up” to “consistent access to routine care”
        • Seen in clinic every 180 days, future visit scheduled
        • Young adults
      • Promote bolusing before meals
      • Tracking smart pen consistent use among MDI users
    • The “Six Habits”: Quality Metrics to Support Glycemic Outcomes in Type 1 Diabetes
      • Overview of process measures and T1D Habits
      • More habits adopted= achieving better glycemic targets
    • Reporting Measures:
      • Phase 1 measures due now for sites that joined on or before 9/1/20.
        • Sites that joined after 9/1/20, Phase 1 measures due 3/31/21
      • Phase 2 measures due by 3/31/21 for sites that joined on or before 9/1/20.
        • Sites that joined after 9/1/20, Phase 2 measures due 6/30/21
      • Phase 3 measures due by 6/30/21 for sites that joined on or before 9/1/20.
        • Sites that joined after 9/1/20, Phase 3 measures due by 9/30/21
      • Sites that joined after 3/1/21: Phase 1 measures due within 90 days of joining; Phase 2 measures due within 120 days of joining; Phase 3 measures due within 180 days of joining.
    • Learning Session Day 1 & 2 Overview (June 14^th and 15^th, 11am-4pm EST)
      • Thematic areas
        • Tracks for new sites/established sites; peds clinics / adult clinics
        • Equity
        • Diabetes Technology
      • Day one breakout sessions
        • QI Toolkit Overview
        • Improving CGM Use
        • Improving Insulin Pump Use
        • Improving CGM Use: Alabama case study
        • Improving Insulin Pump Use: Atlanta case study
        • Device use in adults: Stanford Adult
      • Day two breakout sessions
        • MDI/Smart Pen
        • Tech Use in the U.S. and Internationally
        • AID and Closed Loops
        • Using Technology Data to Drive Population Health
        • Pilot Studies within the QI Collaborative

Next meeting: June 2021 Learning Session

[1] In case of the QI measures/metrics, we define ‘DKA events’ and ‘DKA admissions’ as composite measures derived from the raw DKA data (admissions, events, and patient reported events and admissions.) Metric ‘DKA events’ (implying all DKA events reported) will need to be computed using all types, whereas the ‘DKA admissions’ metric will need to be computed from DKA inpatient admissions and DKA admissions reported from patients, or PROS.

In case of Data mapping, the data spec maps DKA information under four fields (DKA_events_inp_pro, DKA_events_amb_pro, DKA_events_amb, DKA_events_inp)); wherein the first two fields take ‘patient-reported’ DKA events and come from clinical documentation. The latter two fields take DKA events (inpatient/ER/others) that are extracted from the EMR based on relevant codes.

POWERPOINT PRESENTATION